• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静态和动态培养条件下 HepaRG 细胞的基因表达和生物转化活性比较。

Comparison of gene expression and biotransformation activity of HepaRG cells under static and dynamic culture conditions.

机构信息

Wageningen Food Safety Research, P.O. Box 230, 6700 AE, Wageningen, The Netherlands.

出版信息

Sci Rep. 2021 May 14;11(1):10327. doi: 10.1038/s41598-021-89710-6.

DOI:10.1038/s41598-021-89710-6
PMID:33990636
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8121841/
Abstract

Flow conditions have been shown to be important in improving longevity and functionality of primary hepatocytes, but the impact of flow on HepaRG cells is largely unknown. We studied the expression of genes encoding CYP enzymes and transporter proteins and CYP1 and CYP3A4 activity during 8 weeks of culture in HepaRG cells cultured under static conditions (conventional 24-/96-well plate culture with common bicarbonate/CO buffering) and under flow conditions in an organ-on-chip (OOC) device. Since the OOC-device is a closed system, bicarbonate/CO buffering was not possible, requiring application of another buffering agent, such as HEPES. In order to disentangle the effects of HEPES from the effects of flow, we also applied HEPES-supplemented medium in static cultures and studied gene expression and CYP activity. We found that cells cultured under flow conditions in the OOC-device, as well as cells cultured under static conditions with HEPES-supplemented medium, showed more stable gene expression levels. Furthermore, only cells cultured in the OOC-device showed relatively high baseline CYP1 activity, and their gene expression levels of selected CYPs and transporters were most similar to gene expression levels in human primary hepatocytes. However, there was a decrease in baseline CYP3A4 activity under flow conditions compared to HepaRG cells cultured under static conditions. Altogether, the present study shows that HepaRG cells cultured in the OOC-device were more stable than in static cultures, being a promising in vitro model to study hepatoxicity of chemicals upon chronic exposure.

摘要

流动条件已被证明对提高原代肝细胞的寿命和功能很重要,但流动对 HepaRG 细胞的影响在很大程度上尚不清楚。我们研究了在 HepaRG 细胞中培养 8 周时,编码 CYP 酶和转运蛋白的基因表达以及 CYP1 和 CYP3A4 活性,这些细胞在静态条件下(传统的 24-/96 孔板培养,使用常见的碳酸氢盐/CO 缓冲液)和在器官芯片(OOC)设备中进行流动条件下培养。由于 OOC 设备是一个封闭系统,无法使用碳酸氢盐/CO 缓冲液,因此需要应用另一种缓冲剂,如 HEPES。为了将 HEPES 的作用与流动的作用分开,我们还在静态培养中应用了含有 HEPES 的培养基,并研究了基因表达和 CYP 活性。我们发现,在 OOC 设备中进行流动条件下培养的细胞,以及在静态条件下培养的含有 HEPES 的培养基中的细胞,表现出更稳定的基因表达水平。此外,只有在 OOC 设备中培养的细胞显示出相对较高的 CYP1 基础活性,并且它们的选定 CYP 和转运蛋白的基因表达水平与原代人肝细胞的基因表达水平最相似。然而,与在静态条件下培养的 HepaRG 细胞相比,流动条件下的 CYP3A4 基础活性下降。总之,本研究表明,在 OOC 设备中培养的 HepaRG 细胞比在静态培养中更稳定,是研究化学物质慢性暴露引起肝毒性的有前途的体外模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/923aa3d61f1a/41598_2021_89710_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/6b8c9d71663f/41598_2021_89710_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/9038b29b8d3e/41598_2021_89710_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/3074ce123fe0/41598_2021_89710_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/5bc2033abe6f/41598_2021_89710_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/41d2c8d6c876/41598_2021_89710_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/923aa3d61f1a/41598_2021_89710_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/6b8c9d71663f/41598_2021_89710_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/9038b29b8d3e/41598_2021_89710_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/3074ce123fe0/41598_2021_89710_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/5bc2033abe6f/41598_2021_89710_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/41d2c8d6c876/41598_2021_89710_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353d/8121841/923aa3d61f1a/41598_2021_89710_Fig6_HTML.jpg

相似文献

1
Comparison of gene expression and biotransformation activity of HepaRG cells under static and dynamic culture conditions.静态和动态培养条件下 HepaRG 细胞的基因表达和生物转化活性比较。
Sci Rep. 2021 May 14;11(1):10327. doi: 10.1038/s41598-021-89710-6.
2
A two-dimensional multiwell cell culture method for the production of CYP3A4-expressing hepatocyte-like cells from HepaRG cells.一种从 HepaRG 细胞生产表达 CYP3A4 的肝细胞样细胞的二维多孔细胞培养方法。
Pharmacol Res Perspect. 2020 Oct;8(5):e00652. doi: 10.1002/prp2.652.
3
Evaluation of organic anion-transporting polypeptide 1B1 and CYP3A4 activities in primary human hepatocytes and HepaRG cells cultured in a dynamic three-dimensional bioreactor system.在动态三维生物反应器系统中培养的原代人肝细胞和 HepaRG 细胞中有机阴离子转运多肽 1B1 和 CYP3A4 活性的评估。
J Pharmacol Exp Ther. 2012 Oct;343(1):145-56. doi: 10.1124/jpet.112.195750. Epub 2012 Jul 12.
4
Evaluation of CYP3A4 inhibition and hepatotoxicity using DMSO-treated human hepatoma HuH-7 cells.使用二甲基亚砜处理的人肝癌HuH-7细胞评估CYP3A4抑制作用和肝毒性。
Cell Biol Toxicol. 2015 Oct;31(4-5):221-30. doi: 10.1007/s10565-015-9306-9. Epub 2015 Sep 16.
5
3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies.3D 器官型 HepaRG 培养物作为急性和重复剂量毒性研究的体外模型。
Toxicol In Vitro. 2014 Feb;28(1):104-12. doi: 10.1016/j.tiv.2013.06.024. Epub 2013 Jul 9.
6
HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.在生物人工肝中培养的源自HepaRG祖细胞的肝细胞可免受健康和急性肝衰竭血浆诱导的毒性影响。
Cell Physiol Biochem. 2018;48(5):2189-2204. doi: 10.1159/000492560. Epub 2018 Aug 15.
7
Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.稳定表达、活性和可诱导性的细胞色素 P450 在分化的 HepaRG 细胞中。
Drug Metab Dispos. 2010 Mar;38(3):516-25. doi: 10.1124/dmd.109.030197. Epub 2009 Dec 17.
8
Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxide.无二甲亚砜条件下 HepaRG 细胞在生物人工肝中进行的 1 期和 2 期药物代谢和胆汁酸生成。
Drug Metab Dispos. 2013 Mar;41(3):562-7. doi: 10.1124/dmd.112.049098. Epub 2012 Dec 13.
9
Optimisation of the HepaRG cell line model for drug toxicity studies using two different cultivation conditions: advantages and limitations.使用两种不同培养条件优化 HepaRG 细胞系模型用于药物毒性研究:优缺点。
Arch Toxicol. 2022 Sep;96(9):2511-2521. doi: 10.1007/s00204-022-03329-8. Epub 2022 Jun 24.
10
Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.HepaRG细胞、冷冻保存的人肝细胞和HepG2细胞培养物中药物代谢及其相关肝毒性作用的比较
Biol Pharm Bull. 2018 May 1;41(5):722-732. doi: 10.1248/bpb.b17-00913. Epub 2018 Feb 14.

引用本文的文献

1
Current Advances and Future Perspectives of Liver-on-a-Chip Platforms Incorporating Dynamic Fluid Flow.结合动态流体流动的肝芯片平台的当前进展与未来展望
Biomimetics (Basel). 2025 Jul 4;10(7):443. doi: 10.3390/biomimetics10070443.
2
Tumor-specific AAV delivery of interleukin-12 enhances antitumor immunity and safety in ovarian cancer xenograft mouse model.肿瘤特异性腺相关病毒介导的白细胞介素-12递送增强了卵巢癌异种移植小鼠模型中的抗肿瘤免疫和安全性。
Mol Ther Oncol. 2025 May 24;33(2):201002. doi: 10.1016/j.omton.2025.201002. eCollection 2025 Jun 18.
3
Narrative review of 3D bioprinting for the construction of tumor models: present and prospects.

本文引用的文献

1
Implementation of a dynamic intestinal gut-on-a-chip barrier model for transport studies of lipophilic dioxin congeners.用于亲脂性二噁英同系物转运研究的动态肠道芯片上肠道屏障模型的构建
RSC Adv. 2018 Sep 19;8(57):32440-32453. doi: 10.1039/c8ra05430d. eCollection 2018 Sep 18.
2
Microfluidic chip for culturing intestinal epithelial cell layers: Characterization and comparison of drug transport between dynamic and static models.用于培养肠上皮细胞层的微流控芯片:动态和静态模型之间药物传输的特性描述和比较。
Toxicol In Vitro. 2020 Jun;65:104815. doi: 10.1016/j.tiv.2020.104815. Epub 2020 Feb 29.
3
Prediction of in vivo genotoxicity of lasiocarpine and riddelliine in rat liver using a combined in vitro-physiologically based kinetic modelling-facilitated reverse dosimetry approach.
用于构建肿瘤模型的3D生物打印技术的叙述性综述:现状与展望
Transl Cancer Res. 2025 Feb 28;14(2):1479-1491. doi: 10.21037/tcr-2025-128. Epub 2025 Feb 26.
4
Rotating culture regulates the formation of HepaRG-derived liver organoids via YAP translocation.旋转培养通过 YAP 易位调节 HepaRG 来源的肝类器官的形成。
BMC Biol. 2024 Nov 15;22(1):262. doi: 10.1186/s12915-024-02062-1.
5
Advancing Environmental Toxicology : From Immortalized Cancer Cell Lines to 3D Models Derived from Stem Cells.推进环境毒理学:从永生化癌细胞系到源自干细胞的3D模型。
Environ Health (Wash). 2024 Feb 28;2(6):332-349. doi: 10.1021/envhealth.3c00199. eCollection 2024 Jun 21.
6
Effect of cell treatment procedures on in vitro genotoxicity assessment.细胞处理程序对体外遗传毒性评估的影响。
Arch Toxicol. 2024 Apr;98(4):1225-1236. doi: 10.1007/s00204-024-03690-w. Epub 2024 Mar 1.
7
Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models.使用 2D 和 3D HepaRG 细胞模型评估八种亚硝胺的遗传毒性。
Arch Toxicol. 2023 Oct;97(10):2785-2798. doi: 10.1007/s00204-023-03560-x. Epub 2023 Jul 24.
8
Determination of in vitro hepatotoxic potencies of a series of perfluoroalkyl substances (PFASs) based on gene expression changes in HepaRG liver cells.基于 HepaRG 肝细胞基因表达变化测定一系列全氟烷基物质(PFASs)的体外肝毒性效力。
Arch Toxicol. 2023 Apr;97(4):1113-1131. doi: 10.1007/s00204-023-03450-2. Epub 2023 Mar 3.
9
Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review.在下一代化学品风险评估中实施器官芯片:综述。
Arch Toxicol. 2022 Mar;96(3):711-741. doi: 10.1007/s00204-022-03234-0. Epub 2022 Feb 1.
采用体外-基于生理的动力学建模-辅助反向剂量测定方法预测拉西卡品和里德利碱在大鼠肝脏中的体内遗传毒性。
Arch Toxicol. 2019 Aug;93(8):2385-2395. doi: 10.1007/s00204-019-02515-5. Epub 2019 Jul 9.
4
Determination of genotoxic potencies of pyrrolizidine alkaloids in HepaRG cells using the γH2AX assay.利用 γH2AX 检测法测定 HepaRG 细胞中吡咯里西啶生物碱的遗传毒性。
Food Chem Toxicol. 2019 Sep;131:110532. doi: 10.1016/j.fct.2019.05.040. Epub 2019 May 30.
5
Improved oxygenation dramatically alters metabolism and gene expression in cultured primary mouse hepatocytes.改善氧合作用会显著改变原代培养小鼠肝细胞的代谢和基因表达。
Hepatol Commun. 2018 Feb 9;2(3):299-312. doi: 10.1002/hep4.1140. eCollection 2018 Mar.
6
A pump-free microfluidic 3D perfusion platform for the efficient differentiation of human hepatocyte-like cells.一种用于高效分化人肝细胞样细胞的无泵微流控3D灌注平台。
Biotechnol Bioeng. 2017 Oct;114(10):2360-2370. doi: 10.1002/bit.26341. Epub 2017 Jun 27.
7
Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.在微生理系统(MPS)中培养大鼠或人肝细胞以鉴定肝毒性的特征。
Toxicol In Vitro. 2017 Apr;40:170-183. doi: 10.1016/j.tiv.2017.01.007. Epub 2017 Jan 13.
8
Effect of Circulation Parameters on Functional Status of HepaRG Spheroids Cultured in Microbioreactor.循环参数对在微生物反应器中培养的HepaRG球状体功能状态的影响
Bull Exp Biol Med. 2016 Jul;161(3):425-9. doi: 10.1007/s10517-016-3430-2. Epub 2016 Aug 6.
9
Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device.在芯片上肝脏微流控装置中研究非酒精性脂肪性肝病
PLoS One. 2016 Jul 20;11(7):e0159729. doi: 10.1371/journal.pone.0159729. eCollection 2016.
10
Long-term human primary hepatocyte cultures in a microfluidic liver biochip show maintenance of mRNA levels and higher drug metabolism compared with Petri cultures.与培养皿培养相比,微流控肝脏生物芯片中的长期人类原代肝细胞培养显示出mRNA水平的维持和更高的药物代谢能力。
Biopharm Drug Dispos. 2016 Jul;37(5):264-75. doi: 10.1002/bdd.2010.